» Articles » PMID: 6200438

Antigenic Analysis of Japanese Encephalitis Virus by Using Monoclonal Antibodies

Overview
Journal Infect Immun
Date 1984 Apr 1
PMID 6200438
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Hybridoma cells were produced by fusing P3X63Ag8.653 mouse myeloma cells with spleen cells from BALB/c mice immunized with Japanese encephalitis (JE) virus, Nakayama-RFVL strain. The resulting 26 clones produced hemagglutination inhibition antibodies against the homologous strain. The hemagglutination inhibition reactivity of each clone was tested against six flaviviruses: JE, Murray Valley encephalitis (MVE), Egypt 101 strain of West Nile (WN), St. Louis encephalitis (SLE), Russian spring summer encephalitis, and dengue type 1. The 26 monoclonal antibodies fell into four groups: 14 JE species-specific antibodies, 6 antibodies reactive to JE and MVE viruses, 3 antibodies to three or four viruses in the JE-MVE-WN-SLE subgroup, and 3 antibodies to all six flaviviruses. Furthermore, antigenic comparison of 27 strains of JE virus was carried out by using five JE species-specific monoclonal antibodies. Of these, 24 strains were isolated in various parts of Japan, and 3 strains came from Southeast Asia. In reactivity, the 27 strains were classified into at least four antigenic groups. The results showed that the Nakayama-Yakken strain is a mutant strain which lacks the Nakayama strain-specific antigen and that the recently isolated strains are immunologically different from Nakayama and JaGAr 01 strains. One clone (NARMA 13) produced a JE species-specific antibody which showed almost the same titer against 26 JE virus strains, whereas one clone (NARMA 5) produced a Nakayama strain-specific antibody which reacted only to the Nakayama-RFVL and Nakayama-Yoken strains.

Citing Articles

Contrasting the Practices of Virus Isolation and Characterization between the Early Period in History and Modern Times: The Case of Japanese Encephalitis Virus.

Kuno G Viruses. 2022; 14(12).

PMID: 36560644 PMC: 9781737. DOI: 10.3390/v14122640.


Emerging Japanese Encephalitis Virus Genotype V in Republic of Korea.

Lee A, Song J, Seo S J Microbiol Biotechnol. 2022; 32(8):955-959.

PMID: 35879275 PMC: 9628952. DOI: 10.4014/jmb.2207.07002.


Japanese encephalitis virus live attenuated vaccine strains display altered immunogenicity, virulence and genetic diversity.

Davis E, Beck A, Li L, White M, Greenberg M, Thompson J NPJ Vaccines. 2021; 6(1):112.

PMID: 34475404 PMC: 8413339. DOI: 10.1038/s41541-021-00371-y.


Japanese encephalitis vaccines: Immunogenicity, protective efficacy, effectiveness, and impact on the burden of disease.

Hegde N, Gore M Hum Vaccin Immunother. 2017; 13(6):1-18.

PMID: 28301270 PMC: 5529032. DOI: 10.1080/21645515.2017.1285472.


Japanese encephalitis: the virus and vaccines.

Yun S, Lee Y Hum Vaccin Immunother. 2013; 10(2):263-79.

PMID: 24161909 PMC: 4185882. DOI: 10.4161/hv.26902.


References
1.
Peiris J, Gordon S, Unkeless J, PORTERFIELD J . Monoclonal anti-Fc receptor IgG blocks antibody enhancement of viral replication in macrophages. Nature. 1981; 289(5794):189-91. DOI: 10.1038/289189a0. View

2.
Kearney J, Radbruch A, Liesegang B, Rajewsky K . A new mouse myeloma cell line that has lost immunoglobulin expression but permits the construction of antibody-secreting hybrid cell lines. J Immunol. 1979; 123(4):1548-50. View

3.
Clarke D . Antigenic analysis of certain group B arthropodborne viruses by antibody absorption. J Exp Med. 1960; 111:21-32. PMC: 2137198. DOI: 10.1084/jem.111.1.21. View

4.
Casals J . ANTIGENIC VARIANTS OF EASTERN EQUINE ENCEPHALITIS VIRUS. J Exp Med. 1964; 119:547-65. PMC: 2137852. DOI: 10.1084/jem.119.4.547. View

5.
Casals J . Viruses: the versatile parasites; the arthropod-borne group of animal viruses. Trans N Y Acad Sci. 1957; 19(3):219-35. DOI: 10.1111/j.2164-0947.1957.tb00526.x. View